Management of Congenital Methemoglobinemia in the Perioperative Setting: A Case Report and Review of Current Literature
Moncef Ben Ghoulem Ben Saad,Arunabha Karmakar,Tayseer Salih Mohamed Salih,Wajeeha Arshad,Muhammad Jaffar Khan
DOI: https://doi.org/10.2147/jbm.s468072
2024-09-01
Journal of Blood Medicine
Abstract:Moncef Ben Ghoulem Ben Saad, Arunabha Karmakar, Tayseer Salih Mohamed Salih, Wajeeha Arshad, Muhammad Jaffar Khan Department of Anesthesiology, Critical Care and Perioperative MedicineHamad Medical Corporation, Doha, Qatar Correspondence: Muhammad Jaffar Khan, Department of Anesthesiology, Critical Care and Perioperative Medicine, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar, Tel +97444394444, Email Background: Methemoglobin is an altered state of hemoglobin where iron in hemoglobin is oxidized and incapable of binding oxygen; leading to complications such as cyanosis, dyspnea, headache, and heart failure. Methemoglobinemia can be congenital or acquired. Congenital methemoglobinemia is a rare disease and its worldwide incidence is unclear. We recently encountered the first documented case of congenital methemoglobinemia at our institution, necessitating perioperative care. Case Presentation: In the present case, a 22-year-old man with congenital methemoglobinemia underwent general anesthesia for dental extraction. The surgeon was informed to avoid local anesthetics and oxygenation was performed with FiO 2 of 1.0. Arterial blood gas analysis showed a PH of 7.337, PaO 2 of 302 mm Hg, PaCO 2 of 44 mm Hg, oxyhemoglobin level of 63.4%, and methemoglobin level of 37.8%. The patient had a stable course. No methylene blue therapy was required, although cyanosis was observed during surgery. Conclusion: In summary, though rare, congenital methemoglobinemia poses fatal risks during surgery. Its management involves preoperative recognition and optimization, oxygenation status, multidisciplinary care, avoiding precipitating or oxidizing agents, discussing treatment options, maintaining cardiopulmonary stability, and ensuring perioperative safety measures with the medical team. Keywords: methemoglobinemia, general anesthesia, perioperative management, cyanosis, methylene blue Methemoglobin (MetHb) is an altered state of hemoglobin (Hb) containing iron in the Ferric (Fe 3+ ) state rather than Ferrous (Fe 2+ ). Ferric iron cannot bind and transport oxygen. Thus these patients can develop functional anemia and tissue hypoxia. MetHb is normally present in less than 1% of the blood concentration. 1 With higher concentrations, symptoms develop. Methemoglobinemia can be congenital and is usually rare. It can be attributed to either a cytochrome b5 reductase deficiency or the presence of hemoglobin M disease. 2 Acquired methemoglobinemia is however more common and unfortunately more severe. This condition can arise from using different pharmacological agents including nitrates, and local anesthetics such as prilocaine, dapsone, and nitroglycerine (Box 1). 3 We describe the perioperative management of a patient, diagnosed with congenital methemoglobinemia, who required general anesthesia for dental extraction. Box 1 Common Agents Causing MetHb We report a 22-year-old (98 kg bodyweight, 166 cm tall, BMI 35.6) Middle Eastern male, posted for elective extraction of carious wisdom teeth under general anesthesia. He was known to have congenital methemoglobinemia as well as some learning disability. Of note, two years prior, he underwent dental extraction in a dental clinic under local anesthesia, following which, he developed severe cyanosis later in his home, requiring hospital admission and intensive care unit management. The patient also has had multiple previous visits to our hospital emergency department mainly with cyanosis and associated symptoms. Most of the ED visits had culminated in him receiving methylene blue and hydroxycobalamin before being discharged. A hematologist and cardiologist's opinion had been documented in his health records. His co-existing learning disability suggested a diagnosis of Autosomal recessive congenital methemoglobinemia. Echocardiography had ruled out congenital cyanotic heart disease. Armed with the available history, our focus was on the patient's cardio-respiratory fitness. In the pre-anesthesia visit for his current surgery, our patient reassured us that he could comfortably engage in routine physical activities, including walking and climbing stairs, without experiencing headaches, palpitations, or dyspnea. On examination, he had visible bluish discoloration of his fingers and lips. The airway assessment revealed Mallampati grade II, adequate mouth opening, and normal neck movement. Oxygen saturation (SPO2) at the time was measured only 87% on room air. Blood investigations showed secondary polycythemia (Figure 1), Glucose-6-Phosphate Dehydrogenase (G6PD) within normal levels, and methemoglobin at around 3.9–7.1% (Figure 2). Figure 1 Patient had secondary polycythemia with Hb values ranging from 17.5 to 1 -Abstract Truncated-